Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
MDLinx
Lung Cancer Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA reduces risk of ACS in hospitalized pneumonia patients
21 The Contractile Properties of Airway Smooth Muscle: How their Defects can be Linked to Asthmatic Airway Hyperresponsiveness? Current Respiratory Medicine Reviews, May 15, 2013 Review Article
22 Differential Airway Inflammatory Responses in Asthma Exacerbations Induced by Respiratory Syncytial Virus and Influenza Virus A International Archives of Allergy and Immunology, May 15, 2013 Clinical Article
23 Predicting steroid responsiveness in patients with asthma using exhaled breath profiling Clinical & Experimental Allergy, May 15, 2013 Clinical Article
24 Long-term follow-up after two years of asthma treatment guided by airway responsiveness in children Respiratory Medicine, May 14, 2013 Clinical Guideline
25 Respiratory syncytial virus and asthma: speed-dating or long-term relationship? Current Opinion in Pediatrics, May 14, 2013 Review Article
26 Exacerbation of symptoms in agricultural pesticide applicators with asthma International Archives of Occupational & Environmental Health, May 14, 2013 Review Article
27 Asthma Phenotypes and Endotypes: An Evolving Paradigm for Classification Full Text Discovery Medicine, May 14, 2013 Review Article
28 Forced expiratory decay in asthmatic preschool children - Is it adult type? Respiratory Medicine, May 13, 2013 Clinical Article
29 Evaluation of lung function and deposition of aerosolized bronchodilators carried by heliox associated with positive expiratory pressure in stable asthmatics: A randomized clinical trial Respiratory Medicine, May 13, 2013 Clinical Article
30 Screening for Occupational Asthma by Using a Self-Administered Questionnaire in a Clinical Setting Journal of Occupational and Environmental Medicine, May 13, 2013 Clinical Article
31 Role of plasmacytoid dendritic cell subsets in allergic asthma Allergy, May 13, 2013 Review Article
32 Using Orems self-care model for asthmatic adolescents Journal for Specialists in Pediatric Nursing, May 13, 2013 Review Article
33 Efficacy of environmental controls for inhalant allergies Current Opinion in Otolaryngology and Head & Neck Surgery, May 10, 2013 Clinical Article
34 Marine lipid fraction PCSO-524 (lyprinol/omega XL) of the New Zealand green lipped mussel attenuates hyperpnea-induced bronchoconstriction in asthma Respiratory Medicine, May 10, 2013 Clinical Article
35 Inflammometry in pediatric asthma: A review of fractional exhaled nitric oxide in clinical practice Allergy and Asthma Proceedings, May 9, 2013 Review Article
36 Immune circuits in asthma Current Opinion in Pharmacology , May 8, 2013 Review Article
37 Polygenic heritability estimates in pharmacogenetics: focus on asthma and related phenotypes Pharmacogenetics and genomics, May 8, 2013 Clinical Article
38 Exhaled volatile organic compounds predict exacerbations of childhood asthma in a one year prospective study European Respiratory Journal , May 8, 2013 Clinical Article
39 Anosmia and an uncommon nonsteroidal anti-inflammatory drug reaction in a 38-year-old man Allergy and Asthma Proceedings, May 8, 2013
40 Interleukin-1 Receptor and Caspase-1 Are Required for the Th17 Response in Nitrogen Dioxide-Promoted Allergic Airway Disease American Journal of Respiratory Cell and Molecular Biology, May 8, 2013 Review Article
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryAs published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryAs published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summary1 Immunoglobulin G4-related disease mimicking asthma Canadian Respiratory Journal, April 4, 2013
2 Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events Cochrane Reviews, April 2, 2013 Review Article
3 Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis Allergy, April 19, 2013
4 A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation BMC Pulmonary Medicine, March 29, 2013 Free full text
5 Asthma medication delivery: Mists and myths Paediatric Respiratory Reviews, April 12, 2013
6 Exploring the Effects of Omalizumab in Allergic Asthma American Journal of Respiratory and Critical Care Medicine, April 17, 2013
7 Exhaled nitric oxide to predict corticosteroid responsiveness and reduce asthma exacerbation rates Respiratory Medicine, April 22, 2013
8 Add-on omalizumab in children with severe allergic asthma: a one year real life survey European Respiratory Journal , March 25, 2013
9 Exercise training in children with asthma: a systematic review British Journal of Sports Medicine, April 11, 2013 Evidence Based Medicine Review Article
10 Effects of Omalizumab in Non-Atopic Asthma Journal of Asthma, March 25, 2013
11 Association between allergies, asthma, and breast cancer risk among women in Ontario, Canada Cancer Causes and Control, April 25, 2013
12 Evidence for Therapeutic Uses of Nebulized Lidocaine in the Treatment of Intractable Cough and Asthma Annals of Pharmacotherapy, April 10, 2013 Review Article
13 Asthma exacerbations: predisposing factors and prediction rules Current Opinion in Allergy and Clinical Immunology, April 22, 2013
14 Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma: A Systematic Review JAMA, March 27, 2013 Evidence Based Medicine
15 Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study Thorax, April 24, 2013
16 A Randomized Controlled Trial of a Self-Regulation Intervention for Older Adults with Asthma Journal of the American Geriatrics Society, April 26, 2013
17 Pediatric Status Asthmaticus Critical Care Clinics, April 8, 2013 Review Article
18 Development and Preliminary Validation of the Adult Asthma Adherence QuestionnaireTM The Journal of Allergy and Clinical Immunology: In Practice, April 17, 2013
19 Novel Functional Imaging of Changes in Small Airways of Patients Treated with Extrafine Beclomethasone/Formoterol Respiration, April 12, 2013
20 IL-13-producing BLT1-positive CD8 cells are increased in asthma and are associated with airway obstruction Allergy, April 17, 2013 Review Article
Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close